Panel Discussion – What Steps Can Be Taken to Minimize the Impact of Future Disruptions to Global Clinical Studies?

Monday, February 27, 2023

9:50 AM – 10:15 AM ET

Panel Moderator(s)

Kazuhisa Senshu, PhD

Chief clinical and regulatory affairs officer
Terumo Corporation
Tokyo, Japan

Disclosure(s): Terumo Corporation: Employee (Ongoing)
Robert Thatcher, MBA

CEO at Diaxamed
Diaxamed, LLC
Blaine, Minnesota, United States

Disclosure(s): Diaxamed: Board Member/Officer/Trustee (Ongoing), Employee (Ongoing)

Panel Discussant(s)

Andrew Farb, MD

Chief Medical Officer, Division of Cardiovascular Devices
U.S. Food and Drug Administration
Silver Spring, Maryland, United States

No relationships to disclose
Hiroshi Katayama

Principal Reviewer
Pharmaceuticals and Medical Devices Agency

Disclosure information not submitted.
Mitchell Krucoff, MD, FACC (he/him/his)

Professor Medicine/Cardiology
Duke University Medical Center/Duke Clinical Research Institute
Durham, North Carolina, United States

Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Other Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consultant (Ongoing), Other Research Support (Ongoing); Cook medical: Consultant (Ongoing), Other Research Support (Ongoing); Getinge: Consultant (Ongoing), Other Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InfraRedx: Clinical Trial Support (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson & Johnson: Consultant (Ongoing), Other Research Support (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Clinical Trial Support (Ongoing), Consultant (Ongoing), Grant Recipient (Ongoing), Other Research Support (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Nipon: Consultant (Ongoing); OrbusNeich Medical Inc.: Clinical Trial Support (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Terumo Corporation: Other Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Madoka Murakami, PhD

Deputy Director
Ministry of Health, Labour and Welfare, Japan
Chiyoda-ku, Tokyo, Japan

Disclosure(s): No financial relationships to disclose
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure information not submitted.

Disclosure(s):

Kazuhisa Senshu, PhD: Terumo Corporation: Employee (Ongoing)

Robert Thatcher, MBA: Diaxamed: Board Member/Officer/Trustee (Ongoing), Employee (Ongoing)

Mitchell Krucoff, MD, FACC: Abbott Vascular: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Other Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consultant (Ongoing), Other Research Support (Ongoing); Cook medical: Consultant (Ongoing), Other Research Support (Ongoing); Getinge: Consultant (Ongoing), Other Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InfraRedx: Clinical Trial Support (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson & Johnson: Consultant (Ongoing), Other Research Support (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Clinical Trial Support (Ongoing), Consultant (Ongoing), Grant Recipient (Ongoing), Other Research Support (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Nipon: Consultant (Ongoing); OrbusNeich Medical Inc.: Clinical Trial Support (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Terumo Corporation: Other Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Madoka Murakami, PhD: No financial relationships to disclose